Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Jeeva
AddedFeb 15, 2024
UpdatedJun 18, 2026
Jeeva

Jeeva

Angel

Jeeva Informatics: Accelerating rare disease therapy trials using AI and digital health tech.

HQ
Vienna, VA, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to accelerate rare disease therapy trials, Jeeva Informatics Solutions leverages AI and digital health technologies to streamline clinical trial operations. The company aims to bring innovative medicines to market more efficiently by facilitating patient recruitment, enhancing adherence to trial protocols, and reducing patient burden and dropout rates. Jeeva offers a SaaS-based platform that integrates various clinical trial management tools, including EDC and eCOA, to provide a comprehensive solution for biopharmaceutical and medical device companies.

Notable figures affiliated with Jeeva include experts in precision medicine and data science who have contributed significantly to the field. The company has garnered attention from investors focused on healthcare innovation. Key achievements include the successful implementation of their platform in multiple clinical trials, resulting in faster patient recruitment and improved retention rates. Jeeva's impact is evident in its ability to revolutionize clinical trial operations, ultimately empowering better health outcomes through more efficient and patient-friendly trials.

Jeeva - Similar Companies

ClinOne logo

ClinOne

clinone.com

Faro Health logo

Faro Health

farohealth.com

On-Time Trials logo

On-Time Trials

ontimetrials.com

Vial logo

Vial

vialtrials.com

Biogenesis Trials logo

Biogenesis Trials

mybiogenesis.com

iClinical logo

iClinical

FindMeCure logo

FindMeCure

findmecure.com

Power Life Science logo

Power Life Science

withpower.com

Citruslabs logo

Citruslabs

citruslabs.com

Endpoint Clinical logo

Endpoint Clinical

Algorics logo

Algorics

knowRX logo

knowRX

knowrxhealth.com

PatientEvolution logo

PatientEvolution

Jeevam Health logo

Jeevam Health

jeevamhealth.com

Leapcure logo

Leapcure

leapcure.com

Jeeva - Quick Facts

Who are Jeeva's competitors?

Companies similar to Jeeva include ClinOne, Faro Health, On-Time Trials and Vial.

When was Jeeva founded?

Jeeva was founded in 2019.

Where is Jeeva's headquarters located?

Jeeva's headquarters is located in Vienna, VA, US.

When was Jeeva's last funding round?

Jeeva's most recent funding round was for $75k (USD) in June 2023.

How much has Jeeva raised to-date?

As of Jun 27, 2023, Jeeva has raised a total of $2.1M (USD).

How many employees does Jeeva have?

Jeeva has 18 employees as of Feb 4, 2024.

Jeeva - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Clinical Trials
  • Software
Tags
  • Biotech
  • SaaS
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software
Show 10 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7371Computer Programming Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified